+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Drug Delivery Devices Market by Route of Administration (Inhalation, Injectable, Nasal), Vehicles (Dendrimer, Hydrogel, Liposome), Application, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 192 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337868
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Drug Delivery Devices Market size was estimated at USD 227.44 billion in 2023, USD 250.23 billion in 2024, and is expected to grow at a CAGR of 10.93% to reach USD 470.38 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Delivery Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Delivery Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Antares Pharma, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Eisai Co., Ltd., Enable Injections, Inc., Gerresheimer AG, GlaxoSmithKline PLC, Insulet Corporation, Koninklijke Philips N.V., OraSure Technologies, Inc., Smiths Medical, Inc., and West Pharmaceutical Services, Inc.

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Inhalation
    • Injectable
    • Nasal
    • Ocular
    • Oral
    • Topical
    • Transdermal
  • Vehicles
    • Dendrimer
    • Hydrogel
    • Liposome
    • Mesoporous Material
    • Micelle
    • Nanoparticle
    • Niosomes
    • Scaffold
  • Application
    • Autoimmune Diseases
    • Cardiovascular Diseases
    • Central Nervous System Disorders
    • Diabetes
    • Infectious Diseases
    • Oncology
    • Respiratory Diseases
  • End-user
    • Ambulatory Surgery Centers/Clinics
    • Diagnostic Centers
    • Home Care Settings
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Drug Delivery Devices Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Delivery Devices Market?
  3. What are the technology trends and regulatory frameworks in the Drug Delivery Devices Market?
  4. What is the market share of the leading vendors in the Drug Delivery Devices Market?
  5. Which modes and strategic moves are suitable for entering the Drug Delivery Devices Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drug Delivery Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Chronic Diseases Globally Resulting in Increased Demand for Drug Delivery Devices
5.1.1.2. Rise in the Consumption of Drugs and Therapeutic Pharmaceuticals
5.1.2. Restraints
5.1.2.1. Increase in Complications and Expertise Required in Delivering Therapeutics and Drugs
5.1.3. Opportunities
5.1.3.1. Technology Advances in Drug Delivery Devices
5.1.3.2. Rising Adoption of Self Injectable Devices
5.1.4. Challenges
5.1.4.1. Increasing Cost of High End Products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Drug Delivery Devices Market, by Route of Administration
6.1. Introduction
6.2. Inhalation
6.3. Injectable
6.4. Nasal
6.5. Ocular
6.6. Oral
6.7. Topical
6.8. Transdermal
7. Drug Delivery Devices Market, by Vehicles
7.1. Introduction
7.2. Dendrimer
7.3. Hydrogel
7.4. Liposome
7.5. Mesoporous Material
7.6. Micelle
7.7. Nanoparticle
7.8. Niosomes
7.9. Scaffold
8. Drug Delivery Devices Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiovascular Diseases
8.4. Central Nervous System Disorders
8.5. Diabetes
8.6. Infectious Diseases
8.7. Oncology
8.8. Respiratory Diseases
9. Drug Delivery Devices Market, by End-user
9.1. Introduction
9.2. Ambulatory Surgery Centers/Clinics
9.3. Diagnostic Centers
9.4. Home Care Settings
9.5. Hospitals
10. Americas Drug Delivery Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Delivery Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Drug Delivery Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 3M Company
14.1.2. Abbott Laboratories
14.1.3. Antares Pharma, Inc.
14.1.4. B. Braun Melsungen AG
14.1.5. Baxter International Inc.
14.1.6. Becton, Dickinson and Company
14.1.7. Eisai Co., Ltd.
14.1.8. Enable Injections, Inc.
14.1.9. Gerresheimer AG
14.1.10. GlaxoSmithKline PLC
14.1.11. Insulet Corporation
14.1.12. Koninklijke Philips N.V.
14.1.13. OraSure Technologies, Inc.
14.1.14. Smiths Medical, Inc.
14.1.15. West Pharmaceutical Services, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG DELIVERY DEVICES MARKET DYNAMICS
FIGURE 7. DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 8. DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2023 VS 2030 (%)
FIGURE 10. DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Antares Pharma, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Eisai Co., Ltd.
  • Enable Injections, Inc.
  • Gerresheimer AG
  • GlaxoSmithKline PLC
  • Insulet Corporation
  • Koninklijke Philips N.V.
  • OraSure Technologies, Inc.
  • Smiths Medical, Inc.
  • West Pharmaceutical Services, Inc.

Methodology

Loading
LOADING...

Table Information